Related Experiment Videos
Effect of multiple-dose potassium cardioplegia on myocardial ischemia, return of ventricular function, and
Insights
Multiple doses of potassium cardioplegic solution offer superior myocardial protection during cardiac arrest compared to a single dose. This method enhances ventricular function and structural integrity post-ischemia.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Myocardial protection during ischemic arrest is critical in cardiac surgery.
- Optimizing cardioplegic solution delivery can improve outcomes.
- Potassium cardioplegia is a standard method for inducing cardiac arrest.
Purpose of the Study:
- To compare the effectiveness of multiple-dose versus single-dose potassium cardioplegic solution for myocardial protection.
- To evaluate the impact of different cardioplegia regimens on ventricular function and tissue preservation.
- To assess the role of cardioplegia in mitigating myocardial edema and metabolic byproduct accumulation.
Main Methods:
- Isolated feline heart model subjected to 1 hour of ischemic arrest at 27°C.
- Comparison of three groups: no cardioplegia, single-dose, and multiple-dose potassium cardioplegia.
- Measurement of intramyocardial gas tensions, ventricular function, and histological preservation.
Main Results:
- Multiple-dose cardioplegia significantly reduced myocardial carbon dioxide (Pmco2) accumulation compared to single-dose or hypothermia alone.
- Hearts receiving multiple doses showed superior ventricular performance during reperfusion.
- Optimal structural preservation at light and electron microscopy levels was observed with multiple-dose cardioplegia.
Conclusions:
- Multiple-dose potassium cardioplegia provides enhanced myocardial protection compared to single-dose administration.
- Intermittent infusions may facilitate the washout of metabolic end products, improving protection.
- This strategy leads to better functional recovery and histological integrity of the myocardium post-ischemia.
Abstract:
To evaluate the myocardial protection afforded by multiple-dose versus single-dose administration of potassium cardioplegic solution, we studied 24 isolated feline hearts before, during, and after 1 hour of ischemic arrest. Intramyocardial gas tensions, ventricular function, histologic preservation, and postischemic myocardial edema were compared in hearts maintained at 27 degrees C during the ischemic period. Equal groups of hearts received no infusion of cardioplegic solution, a single dose of potassium solution at the onset of ischemia, or multiple infusions of the cardioplegic solution throughout the arrest period. During ischemia, single-dose cardioplegic administration resulted in less accumulation of myocardial carbon dioxide (Pmco2) than did hypothermia alone, reflecting a reduction in metabolic activity during ischemia. The fact that multiple-dose cardioplegia further reduced Pmco2 accumulation suggests an intermittent washout of metabolic end products. During reperfusion, hearts protected by multidose cardioplegia demonstrated superior preservation of ventricular performance compared to hearts protected by single-dose cardioplegia or hypothermia alone. In addition, multiple infusions of the cardioplegic solution resulted in optimal structural preservation in both light and electron microscope studies.